Levosimendan: Effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 2, 1999, Pages 505-514

  Du Toit, E F ^a   Muller, C A ^b   McCarthy, J ^b   Opie, L H ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; LACTIC ACID; LEVOSIMENDAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; GUINEA PIG; HEART ARRHYTHMIA; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CYCLIC AMP; CYCLIC GMP; DOBUTAMINE; GLYBURIDE; GUINEA PIGS; HEART; HYDRAZONES; L-LACTATE DEHYDROGENASE; LACTIC ACID; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NUCLEOTIDES, CYCLIC; PHOSPHOCREATINE; PYRIDAZINES; STEREOISOMERISM;

EID: 0032780899     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Auchampach JA, Maruyama M, Cavero I, Garrett J and Gross J (1992) Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation 86:311-319.
2. Becker LC, Levine JH, DiPaula AF, Gaurnieri T and Aversano T (1986) Reversal of dysfunction in postischaemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol 7:580-589.
3. ATP channel openers protect against increased cytosolic calcium during ischemia and reperfusion. J Mol Cell Cardiol 27:1809-1817.
4. Bolli R (1990) Mechanism of myocardial stunning. Circulation 82:723-738.
5. Coetzee WA and Opie LH (1988) Role of calcium ions in reperfusion arrhythmias: Relevance to pharmacologic intervention. Cardiovasc Drugs Ther 2:623-636.
6. Cole WC, McPherson CD and Sontag D (1991) ATP-regulated channels protect the myocardium against ischemia/reperfusion damage. Circ Res 69:571-581.
7. Du Toit EF, McCarthy J, Miyashiro J, Opie LH and Brunner F (1998) Effects of nitrovasodilators and inhibitors of nitric oxide synthase on ischemic and reperfusion function of the rat isolated hearts. Br J Pharmacol 123:1159-1167.
8. Du Toit EF and Opie LH (1992) Modulation of the severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at the onset of reperfusion. Circ Res 70:960-967.
9. + exchanger in reperfusion stunning in the isolated rat heart. J Cardiovasc Pharmacol 22:877-883.
10. Edes I, Kiss E, Kitada Y, Powers F, Papp J, Kranias E and Solaro RJ (1995) Effect of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and calcium sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 77:107-113.
11. Edwards G and Weston AH (1993) The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 33:597-637.
12. Fitzpatrick DB and Karmazyn M (1984) Comparative effects of calcium channel blocking agents and varying extracellular calcium concentrations on hypoxia/ reoxygenation and ischemia/reperfusion induced cardiac injury. J Pharmacol Exp Ther 228:761-768.
13. Galinanes M, Shattock MJ and Hearse DJ (1992) Effects of potassium channel modulation during global-ischemia in the isolated rat heart with and without cardioplegia. Cardiovasc Res 26:1063-1068.
14. Goto Y, Katsuya H, Takasago T, Saeki A and Nishioka T (1996) Calcium-sensitising drug reduces energy cost for excitation-contraction coupling in the failing heart, but not in the normal heart. Circulation 94(Suppl 8):I545.
15. Grover GJ (1994) Protective effects of ATP sensitive potassium channel openers in models of myocardial ischemia. Cardiovasc Res 28:778-782.
16. Grover GJ, Dzwonczyk S, Parham CS and Sleph PG (1990) The protective effect of cromakalim and pinacidil on reperfusion function and infarct size in the isolated perfused rat hearts and anaesthetised dogs. Cardiovasc Drugs Ther 4:465-474.
17. Grover GJ, Newburger J and Slegh PG (1991) Cardioprotective effects of the potassium channel opener chromakalim: Stereo-selectivity and effect on myocardial adenine nucleotides. J Pharmacol Exp Ther 257:156-162.
18. Haikala H, Kaheinen P, Levijoki J and Linden I-B (1997) The role of cAMP- and cGMP-dependent protein kinase in the cardiac actions of the calcium sensitizer, levosimendan. Cardiovasc Res 34:536-546.
19. Haikala H, Kaivola J, Nissenen E, Wall P, Levijoki J and Linden I-B (1995a) Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. Cell Cardiol 27:1859-1866.
20. Haikala H, Nissenen E, Etemazdadeh E, Levijoki J and Linden I-B (1995b) Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 25:794-801.
21. 2+ current in single heart cells. Nature (Lond) 323:273-275.
22. Hosoda H, Sunamori M, Watanabe M and Suzuki A (1992) Effects of pinacidil combined with potassium cardioplegia on myocardial viability in hypothermic global ischemia followed by perfusion. J Mol Cell Cardiol 24(Suppl 1):S76.
23. Jentzer JH, Lejemtel TH, Sonnenblick EH and Kirk ES (1981) Beneficial effects of amnirone on myocardial oxygen consumption during acute left ventricular failure in dogs. Am J Cardiol 48:75-83.
24. Kihara Y, Grossman W and Morgan JP (1989) Direct measurement of intracellular calcium transients during hypoxia, ischemia and reperfusion in the intact mammalian heart. Circ Res 65:1029-1044.
25. Kusuoka H, Koretsune Y, Chacko VP, Weisfeldt ML and Marban E (1990) Excitation-contraction coupling in post-ischaemic myocardium. Does the failure of activator calcium transients underlie stunning? Circ Res 66:1268-1276.
26. Kusuoka H, Porterfield JK, Weisman HF, Weisfeldt ML and Marban E (1987) Pathophysiology and pathogenesis of the stunned myocardium. J Clin Invest 79:950-961.
27. Lamprecht W and Trautshold I (1963) Methods in Enzymatic Analysis (Bergmeyer H ed) p 543, Academic Press, London.
28. Lubbe W, Podzuweit T and Opie LH (1992) Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: Implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol 19:1622-1633.
29. j in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as to the study of ischemia and reperfusion. Circ Res 66:1255-1267.
30. Mercier JC, Lando U, Kanmatsuse K, Ninomiya K, Meerbaum S, Fishbein MC, Swan HJC and Ganz W (1982) Divergent effects of inotropic stimulation on the ischaemic and severely depressed reperfused myocardium. Circulation 66:397-400.
31. Nayler WJ, Poole-Wilson PA and Williams A (1979) Hypoxia and calcium. J Mol Cell Cardiol 11:683-706.
32. Opie LH (1986) Inodilators. Lancet 1:1336.
33. Rump A, Acar D, Rosen R and Klaus W (1994) Functional and anti-ischemic effects of the phosphodiesterase inhibitor levosimendan in isolated rabbit hearts. Pharmacol Toxicol 74:244-248.
34. Rump A, Rosen R, Sigmund B, Fuchs J, Dhein S and Klaus W (1993) Beneficial effects of amnrinone on the size of acute regional ischemia in isolated rabbit hearts. J Cardiothorac Vasc Anesth 7:573-578.
35. Steenbergen C, Murphy E, Levy L and London RE (1987) Elevation of cytosolic free calcium concentration early in myocardial ischemia in perfused rat hearts. Circ Res 60:700-707.
36. 2+ current in rat ventricular myocytes. Circ Res 77:803-812.
37. + channel in rat ventricular cells. J Pharmacol Exp Ther 283:375-383.
38. + channel in rat arterial myocyte. Eur J Pharmacol 333:249-259.